Top Ten Equity Holdings and Exposures

RNS Number : 9895N

Polar Cap Gbl Healthcare Growth&IT

03 February 2016

 

3^rd February 2016

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

Top Ten Equity Holdings and Sector and Geographic Exposure as at 29- Jan-16 and full Portfolio listing as at 31-Dec-15 available from company's website

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 29^th January 2016 the top ten equity holdings and the sector and geographic breakdown were as follows:

Top 10 Holdings	%
Johnson & Johnson	8.5%
AstraZeneca	7.5%
Eli Lilly & Co	7.4%
Roche	5.7%
Novartis	5.3%
Pfizer	5.0%
Astellas Pharma	3.8%
Merck & Co	3.6%
Bristol Myers Squibb	3.5%
Teva Pharmaceutical Industries	3.3%
Total	53.6%

Sector Exposure	%
Pharmaceuticals	66.1%
Healthcare Equipment	7.1%
Biotechnology	6.4%
Healthcare REITs	4.6%
Healthcare Facilities	4.0%
Healthcare Services	2.2%
Managed Healthcare	1.7%
Healthcare Distributors	1.4%
Healthcare Supplies	0.8%
Life & Health Insurance	0.4%
Life Sciences Tools & Services	0.1%
Cash	5.3%
Total	100.0%

Geographic Exposure	%
United States	44.3%
United Kingdom	15.2%
Switzerland	11.4%
Japan	6.1%
Israel	3.3%
France	3.2%
Ireland	2.6%
Australia	2.3%
Germany	1.8%
Canada	1.8%
Italy	1.1%
India	0.8%
Belgium	0.5%
Norway	0.4%
Cash	5.3%
Total	100%

The monthly factsheet will usually be available on the Company's website on the 10^th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

 

END

 

 

MSCZMGGZKFZGVZM